BNO 5.26% 20.0¢ bionomics limited

Analyst report says Buy, page-18

  1. 593 Posts.
    lightbulb Created with Sketch. 24
    Hi Krugman, take a look at my post on 12/9 or have a look at the edition of Bioshares I refer to. Oncology is being shifted into a new strategic direction. Extract from the posting is below. GLTA

    "... it (BNO) will review the programs in a future issue. It also mentioned the strategy to get out of oncology."
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.